ReviewPediatric nephrology (Berlin, Germany)2026
Monoclonal and monotypic immunoglobulin-related kidney diseases in young people: literature review including evolving entities.
Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Monoclonal gammopathy, paraprotein secreted by a clonal B-lymphoproliferative or plasma cell disorder, is quite rare in children and adolescents and may be transient. Kidney injury related to monoclonal proteins, or monoclonal gammopathy of renal significance (MGRS), is correspondingly rare and may be relatively unfamiliar to pediatric nephrologists when encountering such diagnoses on kidney biopsy (e.g., amyloid, light chain tubulopathy, light chain cast nephropathy). Several recently described glomerulonephritides with monotypic deposits, characterized by deposits of a single heavy chain and a light chain, without a matching clone in serum or bone marrow, are emerging as more common in this age group than true MGRS, such as proliferative glomerulonephritis with monoclonal immunoglobulin deposit (PGNMID), IgA nephropathy with light chain restriction, monotypic membranous nephropathy, and membranous-like nephropathy with masked IgG-kappa (MGMID). PGNMID may arise after infection or other triggers and, in children, is often associated with hypocomplementemia. A recent adult study employing sensitive bone marrow immunoglobulin repertoire sequencing has failed to identify a true clone in many cases, particularly those with IgG3 glomerular deposits. Unfortunately, PGNMID has a propensity for post-transplant recurrence. The pathophysiology, etiology, and treatment for PGNMID and other monotypic entities remain yet to be elucidated in children and adults. Nevertheless, a screening immunofluorescence microscopy panel that includes kappa and lambda light chains is essential for biopsy diagnosis, with confirmation sometimes requiring additional studies such as IgG subclasses and/or antigen retrieval immunofluorescence. This review aims to comprehensively cover monoclonal and monotypic immunoglobulin-related kidney disease in young people.
Indexed as
Identifiers
42624919What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.